A Swiss chemical-pharmaceutical firm that produces active ingredients and intermediate products for generic pharmaceuticals is looking to purchase the totality or majority of shares in a company producing finished pharmaceutical products (especially injectable products) to fill out its catalogue of oncological, cardiovascular and gastro-intestinal products.
Conditions of complete confidentially will apply to the assessment of any proposals received in response to this announcement.